equine anti-doping

The Racing Medication & Testing Consortium (RMTC) has announced that it will fund the research proposal, "Detection of Bisphosphonates Using Metabolomics," submitted by Dr. Bethany Keen at the University of Pennsylvania's Equine Testing and Research Laboratory. Dr. Keen's research to date has been conducted in Australia and focused on equine anti-doping, analytical chemistry, and statistics. Metabolomics is an emerging field in doping control and represents a novel testing approach that identifies cellular effects unique to a class of drugs rather than identifying the specific molecule responsible for those effects. "The...